Poly Medicure Completes Acquisition of Brazilian Medical Device Company MEDYNEO

Poly Medicure Limited has successfully completed the acquisition of Brazilian medical device company MEDYNEO COMERCIO DE PRODUTOS PARA SAUDE LTDA through its wholly owned subsidiary Polymed Brazil LTDA. The transaction was finalized on April 29, 2026, with the company receiving information about the completion on April 30, 2026.

Acquisition Structure and Timeline

Polymed Brazil LTDA executed a Quota Purchase Agreement on April 29, 2026, acquiring 100% equity in MEDYNEO from its existing quotaholders. The acquisition process was completed on the same day, with Polymed Brazil LTDA taking operational control of MEDYNEO, making it a step-down subsidiary of Poly Medicure Limited.

Parameter: Details Acquisition Date: April 29, 2026 Consideration: Brazilian Reais 180,000 Payment Method: Cash Equity Acquired: 100% Completion Status: Fully completed

Target Company Profile

MEDYNEO COMERCIO DE PRODUTOS PARA SAUDE LTDA is a Brazilian limited liability company focused on the importation and commercialization of medical devices. The company was incorporated on July 24, 2025, and operates as a shell entity without past activities, operations, employees, or existing liabilities.

Company Details: Information Business Focus: Importation and commercialization of medical devices Incorporation Date: July 24, 2025 Authorized Capital: Brazilian Reais 20,000 Paid-up Capital: Brazilian Reais 20,000 Current Operations: None Geographic Presence: Brazil

Strategic Rationale

The acquisition provides Poly Medicure with crucial market access capabilities in Brazil's medical device sector. MEDYNEO holds all necessary licenses, permits, and registrations required for legal operation in Brazil's medical device importation and commercialization business segment. This licensing framework enables Polymed Brazil LTDA to immediately commence commercial operations without the typical regulatory approval delays.

Regulatory Compliance

The transaction does not constitute a related party transaction, with no promoter or group company interests in the acquired entity. The acquisition required no governmental or regulatory approvals, streamlining the completion process. The company has disclosed the transaction under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, ensuring full regulatory compliance.

Market Expansion Impact

This acquisition represents Poly Medicure's strategic entry into the Brazilian medical device market through a clean corporate structure. By acquiring a company with established licensing but no operational history or liabilities, Poly Medicure gains immediate market access while maintaining operational flexibility for future business development in Brazil's growing healthcare sector.

Poly Medicure Limited has submitted its quarterly compliance certificate to stock exchanges, fulfilling regulatory requirements under SEBI's depositories regulations for the quarter ended March 31, 2026.

Regulatory Compliance Filing

The company filed the mandatory certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 on April 15, 2026. The submission was made to both BSE Limited and National Stock Exchange of India Limited through Company Secretary Avinash Chandra.

Filing Details: Information Filing Date: April 15, 2026 Quarter Covered: January 1, 2026 to March 31, 2026 Regulation: SEBI Regulation 74(5) Company Secretary: Avinash Chandra (M. No: A32270)

Registrar Confirmation

MAS Services Limited, serving as the company's Registrar & Share Transfer Agent, provided the confirmation certificate dated April 2, 2026. The registrar confirmed compliance with all dematerialization requirements during the specified quarter.

The registrar's certificate verified that:

All securities received from Depository Participants for dematerialization were confirmed within 15 days of receipt

Security certificates were properly mutilated and cancelled after due verification

Depositories were substituted as registered owners in the member register within the mandated timeline

Register of Members was updated accordingly

Process Compliance

Compliance Parameter: Status Dematerialization Timeline: Within 15 days Certificate Processing: Completed as per norms Register Updates: Updated within prescribed limits Stock Exchange Notification: Completed within 15 days

The filing demonstrates the company's adherence to SEBI's regulatory framework governing depositories and participants, ensuring proper handling of securities dematerialization processes during the quarter ended March 31, 2026.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.